<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Tumor protein p63 (TP63)-related ectodermal dysplasias</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Tumor protein p63 (TP63)-related ectodermal dysplasias</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Tumor protein p63 (TP63)-related ectodermal dysplasias</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Timothy J Fete, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Dorothy K Grange, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer L Hand, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rosamaria Corona, MD, DSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 22, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1470163823"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Tumor protein p63 (TP63) is a transcription factor encoded by <em>TP63</em> that plays a vital role in the development and maintenance of the skin and other ectodermal tissues, as well as orofacial structures and limbs. During embryogenesis, <em>TP63</em> is required for epidermal lineage commitment, epidermal differentiation, cell adhesion, and basement membrane formation [<a href="#rid1">1</a>]. Postnatally, the p63 protein is localized to the nuclei of basal cells in the stratified epithelium, including the skin, oral mucosa, cervical and vaginal epithelium, urothelium, and breast [<a href="#rid2">2,3</a>]. <em>TP63</em> maps to chromosome 3q28 and produces six isoforms [<a href="#rid4">4</a>]. Pathogenic variants in different domains of <em>TP63</em> result in different ectodermal dysplasia syndromes with considerable overlapping features [<a href="#rid1">1,5,6</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>ADULT (acro-dermato-ungual-lacrimal-tooth) syndrome (MIM #103285)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>EEC (ectrodactyly, ectodermal dysplasia, and cleft lip/palate) type 3 (EEC3) syndrome (MIM #604292)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>AEC (ankyloblepharon-ectodermal defects-cleft lip/palate) syndrome, also known as Hay-Wells syndrome (MIM #106260)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Limb-mammary syndrome (MIM #603543)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Orofacial cleft 8 (MIM #129400)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Split-hand/foot malformation 4 (MIM #605289)</p><p></p><p><em>TP63</em> variants have been implicated in the pathogenesis of primary ovarian insufficiency [<a href="#rid6">6-9</a>], in which patients experience infertility associated with early arrest of menstruation and high follicle-stimulating hormone before the age of 40. <em>TP63</em> has also been shown to play a role in the pathogenesis of nonsyndromic cleft lip and palate [<a href="#rid10">10</a>]. </p><p>The following sections will expand on EEC3 syndrome and AEC syndrome as representative examples of this group of ectodermal dysplasias. Classic ectodermal dysplasias are discussed separately. Focal dermal hypoplasia (Goltz syndrome) is also discussed separately. (See  <a class="medical medical_review" href="/d/html/110146.html" rel="external">"Ectodermal dysplasias"</a> and  <a class="medical medical_review" href="/d/html/117132.html" rel="external">"Focal dermal hypoplasia (Goltz syndrome)"</a>.)</p><p class="headingAnchor" id="H1397097809"><span class="h1">EEC3 SYNDROME</span><span class="headingEndMark"> — </span>EEC (ectrodactyly, ectodermal dysplasia, and cleft lip/palate) type 3 (EEC3) syndrome is an autosomal dominant disorder characterized by split hands and/or feet; abnormalities of the hair, skin, and teeth; and cleft lip and palate. EEC3 syndrome is caused by missense mutations in the DNA-binding protein domain of <em>TP63 </em>[<a href="#rid11">11</a>]. </p><p class="headingAnchor" id="H1147023277"><span class="h2">Clinical manifestations</span></p><p class="headingAnchor" id="H1473334315"><span class="h3">Cutaneous</span><span class="headingEndMark"> — </span>Individuals with EEC3 syndrome tend to have light-colored hair that is coarse and dry, and it may be sparse. Eyebrows and eyelashes are sparse. Nails are thin, brittle, and occasionally have pits. Skin is dry. Sweating is variable. In one study of 14 patients with EEC3, 9 patients (64 percent) had a normal number of sweat glands and produced sufficient sweat in response to <a class="drug drug_general" data-topicid="9772" href="/d/drug information/9772.html" rel="external">pilocarpine</a>. All others had clearly reduced sweating ability and fewer sweat glands but not anhidrosis [<a href="#rid12">12</a>].</p><p class="headingAnchor" id="H1776750358"><span class="h3">Extracutaneous</span><span class="headingEndMark"> — </span>Extracutaneous manifestations include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dental anomalies</strong> – Hypodontia is common, and teeth can be conical in shape, with poor enamel and an increased risk of caries.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Facial features</strong> – Facial features include midface hypoplasia, a broad nasal tip, and a short philtrum. Cleft lip and/or palate is present in 60 to 75 percent of individuals with EEC3 syndrome.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Limb anomalies</strong> – Limb anomalies include split-hand/foot, syndactyly, oligodactyly, and digital duplication (<a class="graphic graphic_picture graphicRef117087 graphicRef117088" href="/d/graphic/117087.html" rel="external">picture 1A-B</a>) [<a href="#rid5">5,13</a>]. Any combination of one to four extremities can be involved.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Absent lacrimal puncta</strong> – Absent lacrimal puncta occur in most patients, with secondary tearing, dacryocystitis, blepharitis, keratoconjunctivitis, corneal ulceration, and scarring. Research studies are ongoing to create stem cells to potentially treat the corneal damage [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genitourinary anomalies</strong> – Genitourinary tract malformations occur in at least 50 percent of individuals with EEC3 syndrome, including hydroureter, hydronephrosis, renal agenesis, urethral stenosis, micropenis, hypospadias, and cryptorchidism [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Endocrine abnormalities</strong> – Endocrine abnormalities may include growth hormone deficiency, hypogonadotropic hypogonadism, and arginine vasopressin deficiency (previously called central diabetes insipidus) [<a href="#rid16">16</a>].</p><p></p><p>Choanal atresia and rectal stenosis have also been reported in association with EEC3 syndrome [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H320700985"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>Suspicion for EEC3 syndrome should occur in a child with any combination of ectodermal defects associated with cleft lip/palate and/or with limb anomalies. Molecular genetic confirmation can be achieved by sequence analysis of <em>TP63</em> first, followed by gene-targeted deletion/duplication analysis if sequence analysis is normal, or by using a multigene panel that includes <em>TP63</em> (multigene panels vary by laboratory). </p><p class="headingAnchor" id="H1323156730"><span class="h2">Prenatal diagnosis</span><span class="headingEndMark"> — </span>Prenatal testing is available. Preimplantation genetic testing is possible if the familial <em>TP63</em> variant has been identified.</p><p class="headingAnchor" id="H522677118"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>There is considerable clinical overlap and variability in the <em>TP63</em>-related disorders. Consideration of other syndromes within this family is always prudent. Ectrodactyly, ectodermal defects, and cleft lip/palate have been found in nearly 100 percent of classic EEC3 syndrome cases. However, similar findings have been noted to be linked to other chromosomes. As an example, EEC (ectrodactyly, ectodermal dysplasia, and cleft lip/palate) type 1 (EEC1) syndrome (MIM #129900) has been mapped to chromosome 7q21, but the involved gene has not been identified.</p><p class="headingAnchor" id="H416761463"><span class="h2">Management</span><span class="headingEndMark"> — </span>Patients with EEC3 syndrome generally require management by a multidisciplinary team that may include a primary care clinician; dermatologist; geneticist; plastic surgeon; ear, nose, and throat (ENT) specialist; ophthalmologist; speech-language therapist; nutritionist; orthopedic surgeon; urologist; and pediatric dentist, orthodontist, and prosthodontist:</p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation and management of cleft lip/palate, including surgical repair and treatment of associated morbidities, is needed as early as possible. Affected individuals will need close surveillance for recurrent otitis media and otitis media with effusion. Speech and language therapists should be actively involved. A nutritionist should follow children for early feeding difficulties. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In children with hypodontia, early involvement with a pediatric dentist is advised for consideration of early dentures and later team care with orthodontist and prosthodontist as needed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hand and foot anomalies may require evaluation by a plastic surgery team/orthopedic surgery team, including occupational therapy and physical therapy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Early evaluation by a pediatric ophthalmologist is recommended to assess lacrimal puncta and follow closely for complications. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>All individuals with EEC3 syndrome should have evaluation for genitourinary tract anomalies and referral, as necessary, to a pediatric urologist.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children who are not growing as expected should be evaluated for feeding difficulties related to cleft lip and/or palate and may need to be followed by a pediatric feeding team. Referral to a pediatric endocrinologist may also be needed to test for hormonal abnormalities, such as growth hormone deficiency.</p><p></p><p class="headingAnchor" id="H2836870663"><span class="h2">Prognosis</span><span class="headingEndMark"> — </span>The prognosis is overall good for general health and life expectancy.</p><p class="headingAnchor" id="H41406352"><span class="h1">AEC SYNDROME</span><span class="headingEndMark"> — </span>AEC (ankyloblepharon-ectodermal defects-cleft lip/palate) syndrome (MIM #106260), also known as Hay-Wells syndrome, is an autosomal dominant disorder characterized by ankyloblepharon filiforme adnatum that partially or completely fuses the upper and lower eyelids; abnormalities of hair, skin, teeth and nails; and cleft lip and/or palate [<a href="#rid18">18</a>].</p><p>AEC syndrome is caused by mutations in the sterile alpha motif (SAM) domain or the N-terminal domain of <em>TP63</em>. Approximately 70 percent of individuals have a de novo mutation, with only 30 percent having an affected parent [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H2817048670"><span class="h2">Clinical manifestations</span></p><p class="headingAnchor" id="H950439391"><span class="h3">Cutaneous</span><span class="headingEndMark"> — </span>Newborns with AEC syndrome usually present with congenital erythroderma, sometimes appearing as a red, shiny collodion membrane (<a class="graphic graphic_picture graphicRef117093" href="/d/graphic/117093.html" rel="external">picture 2</a>). Superficial skin erosions, most often involving the scalp, are also present at birth (<a class="graphic graphic_picture graphicRef117092" href="/d/graphic/117092.html" rel="external">picture 3</a>) [<a href="#rid19">19,20</a>]. They can be few and scattered or can be diffuse and potentially life threatening, due to fluid and electrolyte disturbance and risk of infection. The scalp erosions can lead to severe scarring and alopecia. The skin erosions can be recurrent throughout childhood, often involving the head and neck, palms, soles, and skin folds. Both hyperpigmentation and hypopigmentation are noted in nearly all individuals with AEC syndrome.</p><p>Hair is light-colored, coarse, wiry, and brittle. Eyelashes and eyebrows are sparse to absent. Nails are absent or dystrophic (<a class="graphic graphic_picture graphicRef117094 graphicRef117095" href="/d/graphic/117094.html" rel="external">picture 4A-B</a>). Sweating is variable. In one study of nine patients with AEC syndrome, three subjects had normal numbers of sweat glands and produced sufficient sweat in response to <a class="drug drug_general" data-topicid="9772" href="/d/drug information/9772.html" rel="external">pilocarpine</a>. All other subjects had clearly reduced sweating ability and fewer sweat glands but not anhidrosis [<a href="#rid12">12</a>].</p><p class="headingAnchor" id="H1409044791"><span class="h3">Extracutaneous</span><span class="headingEndMark"> — </span>Extracutaneous manifestations include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ankyloblepharon</strong> – Approximately 70 percent of individuals with AEC syndrome have ankyloblepharon filiforme adnatum (fusion of the eyelids) (<a class="graphic graphic_picture graphicRef117093" href="/d/graphic/117093.html" rel="external">picture 2</a>), which can be partial or nearly complete. Lacrimal puncta are often absent, leading to chronic conjunctivitis, blepharitis, and keratitis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Facial features</strong> – Cleft lip and/or palate occurs in nearly all cases. Other facial features include maxillary hypoplasia, micrognathia, underdeveloped alae nasi, and short philtrum.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dental anomalies</strong> – Dental anomalies include significant hypodontia and conical teeth.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypospadia</strong> – Hypospadias is common in males [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Poor growth</strong> – Height and weight deficits, requiring nutritional supplementation, are common and may persist through childhood [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Limb anomalies</strong> – Limb anomalies have been reported, including syndactyly and ectrodactyly [<a href="#rid21">21</a>].</p><p></p><p class="headingAnchor" id="H1594900285"><span class="h2">Skin and hair pathology</span><span class="headingEndMark"> — </span>Biopsy samples from clinically unaffected skin shows mild atrophy, focal orthokeratosis, and mild perivascular lymphocytic dermatitis. Scattered melanophages in the superficial and deep dermis likely represent postinflammatory change. Examination of the hair shafts reveals atrophy and loss of melanin. Structural anomalies of the hair include pili torti, pili trianguli et canaliculi, irregular indentation, and shallow grooves [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H2424597816"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>The combination of ankyloblepharon, ectodermal defects, skin erosions (particularly scalp), and cleft lip and/or palate should suggest the diagnosis of AEC syndrome. Molecular testing of <em>TP63</em> is available via sequencing and deletion/duplication analysis. Most of the AEC syndrome variants occur in exons 13 and 14, which encode the SAM and transactivation domains.</p><p class="headingAnchor" id="H44725805"><span class="h2">Prenatal diagnosis</span><span class="headingEndMark"> — </span>Prenatal and preimplantation genetic testing are options for future pregnancies if a pathogenic variant in <em>TP63</em> has been identified in an affected family member.</p><p class="headingAnchor" id="H1269198385"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>Rapp-Hodgkin syndrome is an allelic disorder with AEC, and many experts now consider it to be a variant of AEC syndrome [<a href="#rid24">24</a>]. The lack of ankyloblepharon in Rapp-Hodgkin syndrome is the only significant difference. </p><p>Scalp erosions differentiate AEC syndrome from the other p63 disorders. Although skin erosions at birth could raise the question of epidermolysis bullosa, other manifestations of AEC syndrome should be apparent. </p><p>CHAND (curly hair-ankyloblepharon-nail dysplasia) syndrome has overlapping features with AEC syndrome but lacks skin erosions and cleft lip/palate [<a href="#rid25">25,26</a>].</p><p class="headingAnchor" id="H3144522284"><span class="h2">Management</span><span class="headingEndMark"> — </span>As in EEC3 (ectrodactyly, ectodermal dysplasia, and cleft lip/palate type 3) syndrome, a multidisciplinary team including primary care, nutrition, genetics, dermatology, plastic surgery, ophthalmology, speech and language therapy, audiology, pediatric dentistry, orthodontics, prosthodontists, and potentially others will be required to treat and follow patients with AEC syndrome.</p><p>Skin erosions should be managed in neonatal intensive care settings with careful attention to risk for fluid and electrolyte imbalance, anemia, secondary infection, and sepsis. Erosions should be treated with gentle cleansing and application of skin emollients, whereas aggressive debridement should be avoided.</p><p>Research investigating the use of induced pluripotent stem cells to build patient-derived skin to treat skin erosions is ongoing [<a href="#rid27">27</a>]. An initial trial of topical application of an experimental p53-reactivating compound to skin erosions on two patients allowed for re-epithelialization of the eroded skin and significant decrease in pain [<a href="#rid28">28</a>].</p><p>Ophthalmologic consultation is recommended if eyelid fusion has not resolved spontaneously and for lacrimal duct atresia.</p><p class="headingAnchor" id="H370280691"><span class="h2">Prognosis</span><span class="headingEndMark"> — </span>Prognosis is dependent upon early and aggressive management of potentially life-threatening skin erosions, careful management of fluids and nutrition, and ongoing management of the multiple clinical manifestations noted in AEC syndrome.</p><p class="headingAnchor" id="H2092581470"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetics and phenotypes</strong> – Pathogenic variants in different domains of the <em>TP63 </em>gene, which encodes tumor protein p63 (TP63), a transcription factor involved in the development of the skin, orofacial structures, and limbs, result in different ectodermal dysplasia syndromes with considerable overlapping features. These include (see <a class="local">'Introduction'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>ADULT (acro-dermato-ungual-lacrimal-tooth) syndrome</p><p class="bulletIndent2"><span class="glyph">•</span>EEC (ectrodactyly, ectodermal dysplasia, and cleft lip/palate) type 3 (EEC3) syndrome</p><p class="bulletIndent2"><span class="glyph">•</span>AEC (ankyloblepharon-ectodermal defects-cleft lip/palate) syndrome</p><p class="bulletIndent2"><span class="glyph">•</span>Limb-mammary syndrome</p><p class="bulletIndent2"><span class="glyph">•</span>Orofacial cleft 8</p><p class="bulletIndent2"><span class="glyph">•</span>Split-hand/foot malformation 4</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>EEC3 syndrome</strong> – EEC3 syndrome is an autosomal dominant disorder characterized by split hands and/or feet; abnormalities of the hair, skin, and teeth; and cleft lip/palate. Individuals with EEC3 syndrome present with sparse, coarse, and dry hair; hypodontia; cleft lip/palate; and limb anomalies, including split-hand/foot, syndactyly, and oligodactyly (<a class="graphic graphic_picture graphicRef117087 graphicRef117088" href="/d/graphic/117087.html" rel="external">picture 1A-B</a>). Genitourinary anomalies and endocrine disorders may occur. (See <a class="local">'EEC3 syndrome'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>AEC syndrome</strong> – AEC syndrome is an autosomal dominant disorder characterized by ankyloblepharon filiforme adnatum (partial or complete fusion of the upper and lower eyelids); abnormalities of hair, skin, teeth, and nails; and cleft lip and/or palate. Newborns with AEC syndrome usually present with congenital erythroderma and superficial skin erosions, most often involving the scalp (<a class="graphic graphic_picture graphicRef117093" href="/d/graphic/117093.html" rel="external">picture 2</a> and <a class="graphic graphic_picture graphicRef117092" href="/d/graphic/117092.html" rel="external">picture 3</a>). (See <a class="local">'AEC syndrome'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Patients with EEC3 syndrome and AEC syndrome require management by a multidisciplinary team that includes a primary care clinician; dermatologist; geneticist; plastic surgeon; ear, nose, and throat (ENT) specialist; ophthalmologist; speech-language therapist; nutritionist; orthopedic surgeon; urologist; and pediatric dentist, orthodontist, and prosthodontist. (See <a class="local">'Management'</a> above and <a class="local">'Management'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Koster MI. p63 in skin development and ectodermal dysplasias. J Invest Dermatol 2010; 130:2352.</a></li><li><a class="nounderline abstract_t">Barbieri CE, Pietenpol JA. p63 and epithelial biology. Exp Cell Res 2006; 312:695.</a></li><li><a class="nounderline abstract_t">Casasco M, Icaro Cornaglia A, Riva F, et al. Expression of p63 transcription factor in ectoderm-derived oral tissues. Ital J Anat Embryol 2006; 111:125.</a></li><li><a class="nounderline abstract_t">Di Iorio E, Barbaro V, Ruzza A, et al. Isoforms of DeltaNp63 and the migration of ocular limbal cells in human corneal regeneration. Proc Natl Acad Sci U S A 2005; 102:9523.</a></li><li class="breakAll">Sutton VR, van Bokhoven H. TP63-related disorders. In: GeneReviews, Adam MP, Ardinger HH, Pagon RA, et al (Eds), University of Washington, Seattle, Seattle (WA) 1993.</li><li><a class="nounderline abstract_t">Osterburg C, Osterburg S, Zhou H, et al. Isoform-Specific Roles of Mutant p63 in Human Diseases. Cancers (Basel) 2021; 13.</a></li><li><a class="nounderline abstract_t">Tucker EJ, Gutfreund N, Belaud-Rotureau MA, et al. Dominant TP63 missense variants lead to constitutive activation and premature ovarian insufficiency. Hum Mutat 2022; 43:1443.</a></li><li><a class="nounderline abstract_t">Veitia RA. Primary ovarian insufficiency, meiosis and DNA repair. Biomed J 2020; 43:115.</a></li><li><a class="nounderline abstract_t">Luan Y, Xu P, Yu SY, Kim SY. The Role of Mutant p63 in Female Fertility. Int J Mol Sci 2021; 22.</a></li><li><a class="nounderline abstract_t">Maili L, Letra A, Silva R, et al. PBX-WNT-P63-IRF6 pathway in nonsyndromic cleft lip and palate. Birth Defects Res 2020; 112:234.</a></li><li><a class="nounderline abstract_t">Rinne T, Bolat E, Meijer R, et al. Spectrum of p63 mutations in a selected patient cohort affected with ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (AEC). Am J Med Genet A 2009; 149A:1948.</a></li><li><a class="nounderline abstract_t">Ferstl P, Wohlfart S, Schneider H. Sweating ability of patients with p63-associated syndromes. Eur J Pediatr 2018; 177:1727.</a></li><li><a class="nounderline abstract_t">Buss PW, Hughes HE, Clarke A. Twenty-four cases of the EEC syndrome: clinical presentation and management. J Med Genet 1995; 32:716.</a></li><li><a class="nounderline abstract_t">Barbaro V, Nasti AA, Raffa P, et al. Personalized Stem Cell Therapy to Correct Corneal Defects Due to a Unique Homozygous-Heterozygous Mosaicism of Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome. Stem Cells Transl Med 2016; 5:1098.</a></li><li><a class="nounderline abstract_t">Hyder Z, Beale V, O'Connor R, Clayton-Smith J. Genitourinary malformations: an under-recognized feature of ectrodactyly, ectodermal dysplasia and cleft lip/palate syndrome. Clin Dysmorphol 2017; 26:78.</a></li><li><a class="nounderline abstract_t">Hatipoğlu N, Kurtoğlu S, Büyükayhan D, Akçakuş M. Hypothalamo-pituitary insufficiency associated with ectrodactyly-ectodermal dysplasia-clefting syndrome. J Clin Res Pediatr Endocrinol 2009; 1:252.</a></li><li><a class="nounderline abstract_t">Childs AJ, Mabin DC, Turnpenny PD. Ectrodactyly-ectodermal dysplasia-clefting syndrome presenting with bilateral choanal atresia and rectal stenosis. Am J Med Genet A 2020; 182:1939.</a></li><li><a class="nounderline abstract_t">Fete M, vanBokhoven H, Clements SE, et al. International Research Symposium on Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate (AEC) syndrome. Am J Med Genet A 2009; 149A:1885.</a></li><li><a class="nounderline abstract_t">Julapalli MR, Scher RK, Sybert VP, et al. Dermatologic findings of ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome. Am J Med Genet A 2009; 149A:1900.</a></li><li><a class="nounderline abstract_t">Maillard A, Alby C, Gabison E, et al. P63-related disorders: Dermatological characteristics in 22 patients. Exp Dermatol 2019; 28:1190.</a></li><li><a class="nounderline abstract_t">Sutton VR, Plunkett K, Dang DX, et al. Craniofacial and anthropometric phenotype in ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (Hay-Wells syndrome) in a cohort of 17 patients. Am J Med Genet A 2009; 149A:1916.</a></li><li><a class="nounderline abstract_t">Motil KJ, Fete TJ. Growth, nutritional, and gastrointestinal aspects of ankyloblepharon-ectodermal defect-cleft lip and/or palate (AEC) syndrome. Am J Med Genet A 2009; 149A:1922.</a></li><li><a class="nounderline abstract_t">Dishop MK, Bree AF, Hicks MJ. Pathologic changes of skin and hair in ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome. Am J Med Genet A 2009; 149A:1935.</a></li><li><a class="nounderline abstract_t">Bertola DR, Kim CA, Albano LM, et al. Molecular evidence that AEC syndrome and Rapp-Hodgkin syndrome are variable expression of a single genetic disorder. Clin Genet 2004; 66:79.</a></li><li><a class="nounderline abstract_t">Busa T, Jeraiby M, Clémenson A, et al. Confirmation that RIPK4 mutations cause not only Bartsocas-Papas syndrome but also CHAND syndrome. Am J Med Genet A 2017; 173:3114.</a></li><li><a class="nounderline abstract_t">Bertola DR, Kim CA, Sugayama SM, et al. AEC syndrome and CHAND syndrome: further evidence of clinical overlapping in the ectodermal dysplasias. Pediatr Dermatol 2000; 17:218.</a></li><li><a class="nounderline abstract_t">Koch PJ, Dinella J, Fete M, et al. Modeling AEC-New approaches to study rare genetic disorders. Am J Med Genet A 2014; 164A:2443.</a></li><li><a class="nounderline abstract_t">Aberdam E, Roux LN, Secrétan PH, et al. Improvement of epidermal covering on AEC patients with severe skin erosions by PRIMA-1MET/APR-246. Cell Death Dis 2020; 11:30.</a></li></ol></div><div id="topicVersionRevision">Topic 117131 Version 4.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20445549" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : p63 in skin development and ectodermal dysplasias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16406339" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : p63 and epithelial biology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17312919" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Expression of p63 transcription factor in ectoderm-derived oral tissues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15983386" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Isoforms of DeltaNp63 and the migration of ocular limbal cells in human corneal regeneration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15983386" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Isoforms of DeltaNp63 and the migration of ocular limbal cells in human corneal regeneration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33572532" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Isoform-Specific Roles of Mutant p63 in Human Diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35801529" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Dominant TP63 missense variants lead to constitutive activation and premature ovarian insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32381463" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Primary ovarian insufficiency, meiosis and DNA repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34445673" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The Role of Mutant p63 in Female Fertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31825181" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : PBX-WNT-P63-IRF6 pathway in nonsyndromic cleft lip and palate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19676060" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Spectrum of p63 mutations in a selected patient cohort affected with ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (AEC).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30088137" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Sweating ability of patients with p63-associated syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8544192" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Twenty-four cases of the EEC syndrome: clinical presentation and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27151912" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Personalized Stem Cell Therapy to Correct Corneal Defects Due to a Unique Homozygous-Heterozygous Mosaicism of Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28166087" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Genitourinary malformations: an under-recognized feature of ectrodactyly, ectodermal dysplasia and cleft lip/palate syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21274304" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Hypothalamo-pituitary insufficiency associated with ectrodactyly-ectodermal dysplasia-clefting syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32476291" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Ectrodactyly-ectodermal dysplasia-clefting syndrome presenting with bilateral choanal atresia and rectal stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19353643" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : International Research Symposium on Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate (AEC) syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19681128" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Dermatologic findings of ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31585491" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : P63-related disorders: Dermatological characteristics in 22 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19676059" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Craniofacial and anthropometric phenotype in ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (Hay-Wells syndrome) in a cohort of 17 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19676058" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Growth, nutritional, and gastrointestinal aspects of ankyloblepharon-ectodermal defect-cleft lip and/or palate (AEC) syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19697429" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Pathologic changes of skin and hair in ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15200513" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Molecular evidence that AEC syndrome and Rapp-Hodgkin syndrome are variable expression of a single genetic disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28940926" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Confirmation that RIPK4 mutations cause not only Bartsocas-Papas syndrome but also CHAND syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10886756" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : AEC syndrome and CHAND syndrome: further evidence of clinical overlapping in the ectodermal dysplasias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24665072" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Modeling AEC-New approaches to study rare genetic disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31949132" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Improvement of epidermal covering on AEC patients with severe skin erosions by PRIMA-1MET/APR-246.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
